CoChat

DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma

Open access

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index; none of the 97 sources its claims cite is checked for support yet.

Abstract

DIS3, a key nuclear RNA-degrading enzyme, is essential for immunoglobulin class switch recombination (CSR), promoting activation-induced cytidine deaminase (AID) activity on both DNA strands to induce double-strand DNA breaks. During somatic hypermutation, AID-dependent lesions predominantly occur on the non-template DNA strand. Dominant mutations impairing DIS3 exoribonucleolytic activity are common in multiple myeloma (MM), but their role in carcinogenesis remains unclear. Here we show, using a knock-in mouse model, that the clinically relevant DIS3 G766R variant causes chromosomal translocations in B-cells, characterized by aberrant AID activity signatures. The mice develop pristane-induced plasmacytomas, modeling early-stage MM. In clinical MM samples, DIS3 mutations correlate with IGH translocations and AID-driven lesions in driver genes. Mechanistically, mutated DIS3 accumulates on chromatin-bound RNA, particularly at aberrant AID target sites, promoting mutations on both DNA strands. This results in increased AID-dependent double-strand DNA breaks, fostering microhomology-mediated oncogenic rearrangements. Translocations occur specifically during CSR, which remains functionally intact. The DIS3 G766R mutation does not disrupt chromatin architecture in activated B cells but exploits spatial proximity to permanently juxtapose enhancers and proto-oncogenes, facilitating transformation. Thus, gain-of-function DIS3 mutations enhance AID promiscuity, driving IGH translocations and MM development without broadly affecting B-cell physiology.

Overview

CoChat Summary

TL;DR

In a Dis3 G766R knock-in mouse and clinical MM data, MM-associated DIS3 mutations act as gain-of-function alleles that stall on chromatin-bound RNA, increase AID-dependent double-strand breaks and IGH translocations, and promote plasmacytoma/MM transformation without disrupting CSR or Igh chromatin architecture. The mutant DIS3 does not broadly deregulate the transcriptome/proteome but enhances AID promiscuity at off-target loci.

Key findings

  • Heterozygous Dis3G766R/+ mice are viable with subtle non-coding transcriptome/R-loop changes; homozygous Dis3G766R is embryonically lethal. They show 16 DEGs in naïve B cells, 3 DEGs after 3 days of activation, no DEGs after 5 days, no transcript upregulated >2-fold, and no significant proteome changes, but are smaller and show reduced proliferation.
  • CSR and Igh chromatin architecture remain intact: ~20% of cells switch to IgG1 at day 3 in both genotypes; CoMMpass patients with somatic or germline DIS3 mutations show no CSR disruption; MicroC detects 20,603 WT and 20,279 mutant loops, with no statistically significant difference in 3′RR–Eµ interactions.
  • Pristane-treated Dis3G766R/+ mice develop plasmacytomas at higher incidence than WT (risk ratio 7.19; p = 0.0073) with more Igh translocations and chimeric reads. In CoMMpass, IGH translocations occur in 64.3% of non-recurrent DIS3-mutated patients, 64.5% of recurrent DIS3-mutated patients, and 33.2% of others; AID/DNA-repair signatures are enriched in MM driver genes, with SBS26 at 35% in recurrent, 23% in non-recurrent, and 15% in the rest.
  • Mechanistically, mutant DIS3 stalls on chromatin-bound RNA at AID target sites: DamID libraries from DIS3G766R cells yield 2.5-fold more DNA; DIS3–AID PLA spots increase upon activation; γ-H2AX foci increase in activated Dis3G766R/+ B cells and in CH12F3-2A cells in an AID-dependent manner; AID strand bias is reduced; microhomology at breakpoints is modestly longer (7 bp vs 5 bp in WT); translocations localize near enhancers, promoters, CTCF, and Rad21.

Methods

  • Knock-in Dis3 G766R mice were generated on C57BL/6N and backcrossed to BALB/c for plasmacytoma experiments; primary splenic B cells, MEFs, and CH12F3-2A cells (WT and AID−/−) were used, with in vitro B-cell activation and pristane-induced plasmacytoma as the in vivo model.
  • Assays included RNA-seq, global proteomics, DRIPc-seq, MicroC, DamID-seq, proximity ligation assay, γ-H2AX imaging, flow cytometry, mate-pair and whole-genome DNA sequencing, and analysis of CoMMpass clinical samples.
  • CoMMpass groups comprised 22 patients with recurrent DIS3 mutations, 48 with other DIS3 variants, and 993 with WT DIS3; analyses used DESeq2, SVDetect, Manta, SigProfilerMatrixGenerator, and mmsig.

Limitations

  • Stated in the paper: recurrent MM DIS3 alleles could not be modeled because they cause strong dominant-negative effects and early embryonic lethality, so the study uses the milder heterozygous G766R variant; DIS3 chromatin immunoprecipitation was extremely challenging because its chromatin interaction is indirect and transient; C57BL/6 is naturally resistant to plasmacytoma, requiring BALB/c backcrossing for sufficient WT control material.
  • Evident from the text: the clinical CoMMpass findings are correlative associations between DIS3 mutations, IGH translocations, and mutational signatures, not direct causal proof in human MM; the mouse model is heterozygous-only and may not fully recapitulate human MM progression.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-026-70386-3

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Dis3G766R/+ knock-in mice exhibit mild deregulation of non-coding regions. a MA plot comparing the transcriptomes of primary Dis3G766R/+ and Dis3+/+ B-cells, in vitro activated for 3 days (n = 3 for each genotype). b Correlation of transcriptome changes in the DIS3G766R/+ and DIS3+/+ during in vitro activation for 3 days. c Global proteome MS analysis of Dis3G766R/+ and Dis3+/+ primary B-cells, in vitro activated for 3 days (n = 3 for each genotype). d MA plot comparing RNA/DNA hybrid DRIP-seq signal (with subtracted RNase H control signal) over the annotated transcriptome Dis3G766R/+ and Dis3+/+ B-cells, in vitro activated for 3 days (n = 2 for each genotype). Dashed lines on all plots represent a threshold of 2-fold change. (Statistics for all MA plots: two-sided Wald test with Benjamini–Hochberg multiple-testing correction.) e Meta-analyses of RNA-seq signal over TSS of expressed genes in naïve and day 3 activated B-cells. f Meta-analyses of DRIP-seq signal over TSS of expressed genes in day 3 activated B-cells. g Body weight of male WT and heterozygous littermate Dis3G766R/+ mice aged 30-50 weeks. (Box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR, n = 30 individuals of each genotype plotted as points) h Representative examples of CellTrace™ Yellow proliferation assay performed on splenic B-cells activated in vitro for 3 days. Quantification of CellTrace™ Yellow proliferation assay performed on B-cells activated in vitro for 3 days, with 6 biological replicates per genotype. Statistical analysis was conducted using a two-tailed t-test. Error bars represent the standard deviation. Source data are provided as a Source Data file.
Fig. 1 Dis3G766R/+ knock-in mice exhibit mild deregulation of non-coding regions. a MA plot comparing the transcriptomes of primary Dis3G766R/+ and Dis3+/+ B-cells, in vitro activated for 3 days (n = 3 for each genotype). b Correlation of transcriptome changes in the DIS3G766R/+ and DIS3+/+ during in vitro activation for 3 days. c Global proteome MS analysis of Dis3G766R/+ and Dis3+/+ primary B-cells, in vitro activated for 3 days (n = 3 for each genotype). d MA plot comparing RNA/DNA hybrid DRIP-seq signal (with subtracted RNase H control signal) over the annotated transcriptome Dis3G766R/+ and Dis3+/+ B-cells, in vitro activated for 3 days (n = 2 for each genotype). Dashed lines on all plots represent a threshold of 2-fold change. (Statistics for all MA plots: two-sided Wald test with Benjamini–Hochberg multiple-testing correction.) e Meta-analyses of RNA-seq signal over TSS of expressed genes in naïve and day 3 activated B-cells. f Meta-analyses of DRIP-seq signal over TSS of expressed genes in day 3 activated B-cells. g Body weight of male WT and heterozygous littermate Dis3G766R/+ mice aged 30-50 weeks. (Box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR, n = 30 individuals of each genotype plotted as points) h Representative examples of CellTrace™ Yellow proliferation assay performed on splenic B-cells activated in vitro for 3 days. Quantification of CellTrace™ Yellow proliferation assay performed on B-cells activated in vitro for 3 days, with 6 biological replicates per genotype. Statistical analysis was conducted using a two-tailed t-test. Error bars represent the standard deviation. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Unaffected immunoglobulin class switch recombination in B and MM cells with DIS3 MM variants. a No significant changes in frequencies of switching to the IgG1 class are observed in WT and Dis3G766R/+ B-cells 3 days after activation with lipopolysaccharide and interleukin-4. (Box plots show the median (center line), 25–75th percentiles (box), whiskers to 1.5×IQR. n = 8 Dis3G766R/+ and n = 5 Dis3+/+ individuals) b ELISA of α-SPIKE IgG1 antibodies, 14 days after immunization of mice with Nuvaxovid and Spikevax vaccines. (n = 7 individuals per group, except Nuvaxovid Dis3G766R/+ n = 6; Error bars represent SEM). c No significant changes in frequencies of class switching in WT DIS3 patients or patients with MM-specific DIS3 mutations, both somatic and germline, as determined by the analysis of immunoglobulin heavy and light chain classes expression in RNA-seq experiments. d Flow cytometric analysis revealed a significant expansion of splenic GC B cells (CD95+ GL7+) in immunized versus naïve mice, with a magnitude comparable between DIS3G766R/+ and WT genotypes (n = 8 DIS3G766R/+ n = 7 DIS3+/+ individuals in immunized and n = 3 / genotype for naïve mice; Error bars represent SEM). e DZ (CXCR4high CD86low) and LZ (CXCR4low CD86high) composition was unaffected (n = 8 DIS3G766R/+ n = 7 DIS3+/+ individuals; Error bars represent SEM). f MicroC analysis of chromatin architecture at the Igh locus in wild-type and Dis3G766R/+. Splenic B-cells were activated for 3 days in vitro. Displayed is the normalized interaction matrix at the resolution of 2 kb. Ligation frequencies from two replicates per condition were summed before the normalization. g Distribution of the normalized MicroC signal representing DNA interactions between the 3′RR super-enhancer and the Eµ intronic enhancer in Dis3G766R/+ and Dis3+/+ primary B-cells (Box plots show the median - center line, 25–75th percentiles - box, whiskers to 1.5×IQR, and outliers as individual points; separate for each individual n = 2, see box in f for the annotation of the interacting genomic intervals). Differences in all pairwise comparisons are not statistically significant. h CTCF and i Rad21 ChIP-seq signal in the Igh locus. All statistical analyses were performed using two-sided, Wilcoxon rank-sum test. Source data are provided as a Source Data file.
Fig. 2 Unaffected immunoglobulin class switch recombination in B and MM cells with DIS3 MM variants. a No significant changes in frequencies of switching to the IgG1 class are observed in WT and Dis3G766R/+ B-cells 3 days after activation with lipopolysaccharide and interleukin-4. (Box plots show the median (center line), 25–75th percentiles (box), whiskers to 1.5×IQR. n = 8 Dis3G766R/+ and n = 5 Dis3+/+ individuals) b ELISA of α-SPIKE IgG1 antibodies, 14 days after immunization of mice with Nuvaxovid and Spikevax vaccines. (n = 7 individuals per group, except Nuvaxovid Dis3G766R/+ n = 6; Error bars represent SEM). c No significant changes in frequencies of class switching in WT DIS3 patients or patients with MM-specific DIS3 mutations, both somatic and germline, as determined by the analysis of immunoglobulin heavy and light chain classes expression in RNA-seq experiments. d Flow cytometric analysis revealed a significant expansion of splenic GC B cells (CD95+ GL7+) in immunized versus naïve mice, with a magnitude comparable between DIS3G766R/+ and WT genotypes (n = 8 DIS3G766R/+ n = 7 DIS3+/+ individuals in immunized and n = 3 / genotype for naïve mice; Error bars represent SEM). e DZ (CXCR4high CD86low) and LZ (CXCR4low CD86high) composition was unaffected (n = 8 DIS3G766R/+ n = 7 DIS3+/+ individuals; Error bars represent SEM). f MicroC analysis of chromatin architecture at the Igh locus in wild-type and Dis3G766R/+. Splenic B-cells were activated for 3 days in vitro. Displayed is the normalized interaction matrix at the resolution of 2 kb. Ligation frequencies from two replicates per condition were summed before the normalization. g Distribution of the normalized MicroC signal representing DNA interactions between the 3′RR super-enhancer and the Eµ intronic enhancer in Dis3G766R/+ and Dis3+/+ primary B-cells (Box plots show the median - center line, 25–75th percentiles - box, whiskers to 1.5×IQR, and outliers as individual points; separate for each individual n = 2, see box in f for the annotation of the interacting genomic intervals). Differences in all pairwise comparisons are not statistically significant. h CTCF and i Rad21 ChIP-seq signal in the Igh locus. All statistical analyses were performed using two-sided, Wilcoxon rank-sum test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Predisposition to plasmacytoma development in Dis3G766R/+ knock-in mice is accompanied by frequent Igh translocations. a Kaplan-Meier survival plot of male WT and Dis3G766R/+ aged mice. b Incidence of WT and Dis3G766R/+ mice developing diffuse alveolar hemorrhage together with a generalized autoimmune phenotype in response to a peritoneal injection of pristane. c Cumulative incidence plot showing the frequency of plasmacytoma in Dis3G766R/+ and WT mice after the pristane injection. Note that the Dis3G766R mouse line was constructed on a C57BL/6 N genetic background, naturally resistant to plasmacytoma development. d Circos plot illustrates translocations that involve the IGH locus detected in plasmacytoma cells isolated from Dis3G766R/+ mice (red) and WT mice (green). e Fraction of chimeric reads in plasmacytoma samples isolated from Dis3G766R/+ and WT mice identified using standard whole-genome DNA sequencing (top) and the sequencing of mate-pair libraries (bottom). Source data are provided as a Source Data file.
Fig. 3 Predisposition to plasmacytoma development in Dis3G766R/+ knock-in mice is accompanied by frequent Igh translocations. a Kaplan-Meier survival plot of male WT and Dis3G766R/+ aged mice. b Incidence of WT and Dis3G766R/+ mice developing diffuse alveolar hemorrhage together with a generalized autoimmune phenotype in response to a peritoneal injection of pristane. c Cumulative incidence plot showing the frequency of plasmacytoma in Dis3G766R/+ and WT mice after the pristane injection. Note that the Dis3G766R mouse line was constructed on a C57BL/6 N genetic background, naturally resistant to plasmacytoma development. d Circos plot illustrates translocations that involve the IGH locus detected in plasmacytoma cells isolated from Dis3G766R/+ mice (red) and WT mice (green). e Fraction of chimeric reads in plasmacytoma samples isolated from Dis3G766R/+ and WT mice identified using standard whole-genome DNA sequencing (top) and the sequencing of mate-pair libraries (bottom). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 DIS3-dependent translocations in mouse plasmacytomas have AID target characteristics. a–j Meta-analyses of genomic regions engaged in translocations with features specific for sites of AID activity: AID ChIP-seq signal (a), GC-rich regions (b), AID-specific DNA recognition sequence motifs (c), predicted G-quadruplex sequences (d), WT (e) and Dis3G766R/+ (f) RNA-seq of day 3 activated B-cells, native transcription measured by GRO-seq (g) and WT (h) and Dis3G766R/+ (i) DRIP-seq signal of day 3 activated B-cells, relative to random genomic distribution. j Meta-analyses of DRIP-seq signal from Dis3+/+ and Dis3G766R/+ over known AID target loci. k UCSC genome browser snapshot of a fragment of the IGH locus that shows the clustering of translocation sites with regions that coincide with the enrichment of AID-specific recognition sequence motifs, G-quadruplexes, R-loops, active bidirectional transcription, and AID occupancy.
Fig. 4 DIS3-dependent translocations in mouse plasmacytomas have AID target characteristics. a–j Meta-analyses of genomic regions engaged in translocations with features specific for sites of AID activity: AID ChIP-seq signal (a), GC-rich regions (b), AID-specific DNA recognition sequence motifs (c), predicted G-quadruplex sequences (d), WT (e) and Dis3G766R/+ (f) RNA-seq of day 3 activated B-cells, native transcription measured by GRO-seq (g) and WT (h) and Dis3G766R/+ (i) DRIP-seq signal of day 3 activated B-cells, relative to random genomic distribution. j Meta-analyses of DRIP-seq signal from Dis3+/+ and Dis3G766R/+ over known AID target loci. k UCSC genome browser snapshot of a fragment of the IGH locus that shows the clustering of translocation sites with regions that coincide with the enrichment of AID-specific recognition sequence motifs, G-quadruplexes, R-loops, active bidirectional transcription, and AID occupancy.CC BY · PubMed Central
Fig. 5 Mutational signatures reveal increases in AID and DNA damage repair lesions on MM driver genes in DIS3 mutant patients. a Circos graphs depicting the MM driver translocations of the IGH locus in WT DIS3 CoMMpass patients vs. patients with somatic non-recurrent and recurrent DIS3 MM variants. b Bar plot of the enrichment of IGH MM-specific translocations in DIS3 mutant patients of different genotypes compared with WT DIS3 patients. (Statistical significance was assessed using a two-sided Fisher’s exact test.) c–g Contribution of COSMIC mutational signatures in all somatic single-nucleotide variants (SNVs) acquired by CoMMpass patients with WT DIS3, a mutant DIS3, or a recurrent MM DIS3 variant in whole exome sequencing (WES): exome-wide (c), in all somatic DIS3 mutations (d), expressed PROMPTs (e), in genes known to be AID off-targets (f) and in MM driver genes (g).
Fig. 5 Mutational signatures reveal increases in AID and DNA damage repair lesions on MM driver genes in DIS3 mutant patients. a Circos graphs depicting the MM driver translocations of the IGH locus in WT DIS3 CoMMpass patients vs. patients with somatic non-recurrent and recurrent DIS3 MM variants. b Bar plot of the enrichment of IGH MM-specific translocations in DIS3 mutant patients of different genotypes compared with WT DIS3 patients. (Statistical significance was assessed using a two-sided Fisher’s exact test.) c–g Contribution of COSMIC mutational signatures in all somatic single-nucleotide variants (SNVs) acquired by CoMMpass patients with WT DIS3, a mutant DIS3, or a recurrent MM DIS3 variant in whole exome sequencing (WES): exome-wide (c), in all somatic DIS3 mutations (d), expressed PROMPTs (e), in genes known to be AID off-targets (f) and in MM driver genes (g).CC BY · PubMed Central
Fig. 6 Mutant DIS3 stalling on chromatin-bound substrates, resulting in increased AID-dependent DNA damage in activated B-cells. a Mean intensities of DamID libraries obtained from activated CH12F3-2A cells that express WT and DIS3G766R. (One-sided unpaired homoscedastic t-test; error bars = SD). b DIS3 DamID-seq in activated CH12F3-2A cells shows signal enrichment compared with the rest of the genome over regions that translocate in plasmacytomas and represent known DIS3 substrates, such as PROMPTs (n = 3 / genotype; Mood’s median test). c GRO-seq shows enrichment of native transcription at the same genomic sites. d Representative confocal microscopy images demonstrating DIS3 and AID interaction in CH12F3-2A cells detected by in situ PLA (Scale bars = 10μm. Representative images from one high-throughput microscopy experiment are shown; quantification (adjacent panel) is derived from the same experiment. All required controls are present in the Supplementary Fig. S8a). e Quantification of the number of DIS3 and AID interaction sites (PLA spots) in CH12F3-2A. Analysis was restricted to cells with at least one PLA spot identified (PLA-positive cells). The black horizontal lines represent means. (Statistics: two-sided, Wilcoxon rank-sum test; n = 1076 nuclei in activated and n = 209 nuclei in naïve Ch12F3-2A cells) f Representative images demonstrating γ-H2AX staining in naïve and day 3 activated B-cells (Scale bars = 10 μm. green, merged with DAPI in blue). g Quantification of number of γ-H2AX immunofluorescent spots. (Statistics: two-sided, Wilcoxon rank-sum test; n = 2418 nuclei in activated and n = 209 nuclei in naïve). h Quantification of high-throughput confocal imaging of DNA double-strand breaks, defined as the number of γ-H2AX foci per nucleus, in naïve and activated CH12F3-2A cells showed that DIS3G766R expression led to elevated γ-H2AX levels in an AID-dependent manner. (Statistics: two-sided, Wilcoxon rank-sum test, Bonferroni-corrected, AID+/+: n = 3959 DIS3WT n = 5381 DIS3G766R; AID-/-: n = 13087 DIS3WT n = 12543 DIS3G766R activated CH12F3-2A cells). i Directional meta-analyses of RNA-seq signals from day 3 activated B cells over somatically mutated cytidines in plasmacytoma samples of DIS3G766R/+ mice show decreased specificity of AID mutagenic activity for the coding strand compared to DIS3+/+ counterparts. All box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR.
Fig. 6 Mutant DIS3 stalling on chromatin-bound substrates, resulting in increased AID-dependent DNA damage in activated B-cells. a Mean intensities of DamID libraries obtained from activated CH12F3-2A cells that express WT and DIS3G766R. (One-sided unpaired homoscedastic t-test; error bars = SD). b DIS3 DamID-seq in activated CH12F3-2A cells shows signal enrichment compared with the rest of the genome over regions that translocate in plasmacytomas and represent known DIS3 substrates, such as PROMPTs (n = 3 / genotype; Mood’s median test). c GRO-seq shows enrichment of native transcription at the same genomic sites. d Representative confocal microscopy images demonstrating DIS3 and AID interaction in CH12F3-2A cells detected by in situ PLA (Scale bars = 10μm. Representative images from one high-throughput microscopy experiment are shown; quantification (adjacent panel) is derived from the same experiment. All required controls are present in the Supplementary Fig. S8a). e Quantification of the number of DIS3 and AID interaction sites (PLA spots) in CH12F3-2A. Analysis was restricted to cells with at least one PLA spot identified (PLA-positive cells). The black horizontal lines represent means. (Statistics: two-sided, Wilcoxon rank-sum test; n = 1076 nuclei in activated and n = 209 nuclei in naïve Ch12F3-2A cells) f Representative images demonstrating γ-H2AX staining in naïve and day 3 activated B-cells (Scale bars = 10 μm. green, merged with DAPI in blue). g Quantification of number of γ-H2AX immunofluorescent spots. (Statistics: two-sided, Wilcoxon rank-sum test; n = 2418 nuclei in activated and n = 209 nuclei in naïve). h Quantification of high-throughput confocal imaging of DNA double-strand breaks, defined as the number of γ-H2AX foci per nucleus, in naïve and activated CH12F3-2A cells showed that DIS3G766R expression led to elevated γ-H2AX levels in an AID-dependent manner. (Statistics: two-sided, Wilcoxon rank-sum test, Bonferroni-corrected, AID+/+: n = 3959 DIS3WT n = 5381 DIS3G766R; AID-/-: n = 13087 DIS3WT n = 12543 DIS3G766R activated CH12F3-2A cells). i Directional meta-analyses of RNA-seq signals from day 3 activated B cells over somatically mutated cytidines in plasmacytoma samples of DIS3G766R/+ mice show decreased specificity of AID mutagenic activity for the coding strand compared to DIS3+/+ counterparts. All box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR.CC BY · PubMed Central
Fig. 7 Model of the involvement of MM-specific DIS3 variants in MM oncogenesis through enhanced AID recruitment to ssDNA. a–d Distributions of distances of regions translocating in murine plasmacytomas to the closest ChIP-seq peaks of: H3K4me1 or H3K4me3, both overlapping with H3K27ac (n = 55803 H3K4me1peaks; n = 25353 H3K4me3 peaks) (a), p300 (n = 20159 peaks) (b), CTCF (n = 81036 peaks) (c) and Rad21 (n = 85771 peaks) (d). (Box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR. Two-sided, Wilcoxon rank-sum test, Bonferroni-corrected). e Representative example of an intrachromosomal interaction accompanying Igh-derived translocation t(10,12) in murine-induced plasmacytoma. f AID is recruited to DNA during class switch recombination (CSR) through transcription-generated single-stranded DNA regions. These regions serve as substrates for AID, initiating CSR and ultimately producing antibodies with altered functions. The nuclear exosome with WT DIS3 recruits AID to transcribed sequences, but due to the transient AID activity outside the Igh locus, such events are rare. g MM DIS3 variants increase AID activity by enhancing the affinity of the nuclear RNA exosome, resulting in increased occupancy/stalling. This results in the accumulation of uracil bases in off-target regions. h DNA damage repair mechanisms, including base excision repair (BER) and mismatch repair (MMR) involving uracil glycosylase and AP-endonucleases, process AID introduced uracils, inducing double-strand breaks (DSBs). i Non-homologous end joining (NHEJ) and microhomology-mediated end joining (MMEJ) rejoin the free DNA ends, but excessive DSBs can lead to unrestrained genome rearrangements. Source data are provided as a Source Data file.
Fig. 7 Model of the involvement of MM-specific DIS3 variants in MM oncogenesis through enhanced AID recruitment to ssDNA. a–d Distributions of distances of regions translocating in murine plasmacytomas to the closest ChIP-seq peaks of: H3K4me1 or H3K4me3, both overlapping with H3K27ac (n = 55803 H3K4me1peaks; n = 25353 H3K4me3 peaks) (a), p300 (n = 20159 peaks) (b), CTCF (n = 81036 peaks) (c) and Rad21 (n = 85771 peaks) (d). (Box plots show the median (center line), 25th–75th percentiles (box), whiskers to 1.5×IQR. Two-sided, Wilcoxon rank-sum test, Bonferroni-corrected). e Representative example of an intrachromosomal interaction accompanying Igh-derived translocation t(10,12) in murine-induced plasmacytoma. f AID is recruited to DNA during class switch recombination (CSR) through transcription-generated single-stranded DNA regions. These regions serve as substrates for AID, initiating CSR and ultimately producing antibodies with altered functions. The nuclear exosome with WT DIS3 recruits AID to transcribed sequences, but due to the transient AID activity outside the Igh locus, such events are rare. g MM DIS3 variants increase AID activity by enhancing the affinity of the nuclear RNA exosome, resulting in increased occupancy/stalling. This results in the accumulation of uracil bases in off-target regions. h DNA damage repair mechanisms, including base excision repair (BER) and mismatch repair (MMR) involving uracil glycosylase and AP-endonucleases, process AID introduced uracils, inducing double-strand breaks (DSBs). i Non-homologous end joining (NHEJ) and microhomology-mediated end joining (MMEJ) rejoin the free DNA ends, but excessive DSBs can lead to unrestrained genome rearrangements. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 47 Not checked · 134 Own results and interpretations

88 more claims

Create a free account to see all 181 claims and to verify the 97 references still open.

See all claims — free account
  • It may state two separate claims as one. 55
  • Probably not a substantial claim. 43

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 117 references

Research works printed but not linked: 1

  1. Laffleur, B. et al. RNA exosome drives early B cell development via noncoding RNA processing mechanisms. Sci. Immunol. 7, 1–14 (2022). PMC9357289 35658015 · DOI · Paper page

Cited by

See all 7

Metadata

Authors
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., Pękowska, A., Séraphin, B., & Dziembowski, A.
Affiliations
  • International Institute of Molecular and Cell Biology (PL)
  • Centre National de la Recherche Scientifique (FR)
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences (PL)
  • Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL)
Corresponding author
  • Kuliński, Tomasz M.
  • Dziembowski, Andrzej
Venue
Nature Communications
Published
2026-03-14
Volume
17
Issue
1
Pages
3976
ISSN
2041-1723 (ISSN-L)
OpenAlex
W7135404926
Cited by
7
References
116
Citations by year
2026: 4
FWCI
12.31
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Narodowe Centrum Nauki (UMO-2016/22/A/NZ4/00380, UMO-2013/10/M/NZ4/00299, UMO-2019/33/B/NZ2/02437, UMO-2021/43/B/NZ2/02934, UMO-2021/42/E/NZ2/00392)
  • EC | Horizon 2020 Framework Programme (810425)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Keywords
DIS3, multiple myeloma, activation-induced cytidine deaminase, immunoglobulin class switch recombination, somatic hypermutation, chromosomal translocation, IGH translocation, B cell activation, DNA double-strand breaks, gain-of-function mutations
MeSH terms
AICDA (Activation-Induced Cytidine Deaminase), Animals, B-Lymphocytes, Cell Transformation, Neoplastic, Cytidine Deaminase, Humans, Lymphocyte Activation, Multiple Myeloma, Mutation, Translocation, Genetic, Immunoglobulin Class Switching, Mice, DNA Breaks, Double-Stranded, Exosome Multienzyme Ribonuclease Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma. https://app.cochat.ai/papers/10.1038/s41467-026-70386-3
The paper
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., Pękowska, A., Séraphin, B., & Dziembowski, A. (2026). DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma. Nature Communications. https://doi.org/10.1038/s41467-026-70386-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.